Your browser doesn't support javascript.
loading
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases.
Tonello, M; Baratti, D; Sammartino, P; Di Giorgio, A; Robella, M; Sassaroli, C; Framarini, M; Valle, M; Macrì, A; Graziosi, L; Coccolini, F; Lippolis, P V; Gelmini, R; Deraco, M; Biacchi, D; Aulicino, M; Vaira, M; De Franciscis, S; D'Acapito, F; Carboni, F; Milone, E; Donini, A; Fugazzola, P; Faviana, P; Sorrentino, L; Pizzolato, E; Cenzi, C; Del Bianco, P; Sommariva, A.
Affiliation
  • Tonello M; Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua.
  • Baratti D; Peritoneal Surface Malignancy Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Sammartino P; Cytoreductive Surgery and HIPEC Unit, Department of Surgery 'Pietro Valdoni', Sapienza University of Rome, Rome.
  • Di Giorgio A; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli, Rome.
  • Robella M; Surgical Oncology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin.
  • Sassaroli C; Integrated Medical Surgical Research in Peritoneal Surface Malignancy, Abdominal Oncology Department, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Pascale IRCCS, Naples.
  • Framarini M; General and Oncologic Department of Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì.
  • Valle M; Peritoneal Tumours Unit, IRCCS, Regina Elena Cancer Institute, Rome.
  • Macrì A; Peritoneal and Retroperitonel Surgical Unit-University Hospital 'G. Martino' Messina.
  • Graziosi L; General and Emergency Surgery Department, University of Perugia, Santa Maria Della Misericordia Hospital, Perugia.
  • Coccolini F; General Emergency and Trauma Surgery, Bufalini Hospital, Cesena; General Emergency and Trauma Surgery, Pisa University Hospital, Pisa.
  • Lippolis PV; General and Peritoneal Surgery, Department of Surgery, Hospital University Pisa (AOUP), Pisa.
  • Gelmini R; General and Oncological Surgery Unit, AOU of Modena University of Modena and Reggio Emilia.
  • Deraco M; Peritoneal Surface Malignancy Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Biacchi D; Cytoreductive Surgery and HIPEC Unit, Department of Surgery 'Pietro Valdoni', Sapienza University of Rome, Rome.
  • Aulicino M; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli, Rome.
  • Vaira M; Surgical Oncology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin.
  • De Franciscis S; Colorectal Surgical Oncology, Abdominal Oncology Department, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Pascale IRCCS, Naples.
  • D'Acapito F; General and Oncologic Department of Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì.
  • Carboni F; Peritoneal Tumours Unit, IRCCS, Regina Elena Cancer Institute, Rome.
  • Milone E; Peritoneal and Retroperitonel Surgical Unit-University Hospital 'G. Martino' Messina.
  • Donini A; General and Emergency Surgery Department, University of Perugia, Santa Maria Della Misericordia Hospital, Perugia.
  • Fugazzola P; General surgery, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Faviana P; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa.
  • Sorrentino L; General and Oncological Surgery Unit, AOU of Modena University of Modena and Reggio Emilia.
  • Pizzolato E; Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua.
  • Cenzi C; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Del Bianco P; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Sommariva A; Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua. Electronic address: antonio.sommariva@iov.veneto.it.
ESMO Open ; 9(4): 102976, 2024 Apr.
Article de En | MEDLINE | ID: mdl-38613907
ABSTRACT

BACKGROUND:

There is little evidence on KRAS mutational profiles in colorectal cancer (CRC) peritoneal metastases (PM). This study aims to determine the prevalence of specific KRAS mutations and their prognostic value in a homogeneous cohort of patients with isolated CRC PM treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MATERIALS AND

METHODS:

Data were collected from 13 Italian centers, gathered in a collaborative group of the Italian Society of Surgical Oncology. KRAS mutation subtypes have been correlated with clinical and pathological characteristics and survival [overall survival (OS), local (peritoneal) disease-free survival (LDFS) and disease-free survival (DFS)].

RESULTS:

KRAS mutations occurred in 172 patients (47.5%) out of the 362 analyzed. Two different prognostic groups of KRAS mutation subtypes were identified KRASMUT1 (G12R, G13A, G13C, G13V, Q61H, K117N, A146V), median OS > 120 months and KRASMUT2 (G12A, G12C, G12D, G12S, G12V, G13D, A59E, A59V, A146T), OS 31.2 months. KRASMUT2 mutations mainly occurred in the P-loop region (P < 0.001) with decreased guanosine triphosphate (GTP) hydrolysis activity (P < 0.001) and were more frequently related to size (P < 0.001) and polarity change (P < 0.001) of the substituted amino acid (AA). When KRASMUT1 and KRASMUT2 were combined with other known prognostic factors (peritoneal cancer index, completeness of cytoreduction score, grading, signet ring cell, N status) in multivariate analysis, KRASMUT1 showed a similar survival rate to KRASWT patients, whereas KRASMUT2 was independently associated with poorer prognosis (hazard ratios OS 2.1, P < 0.001; DFS 1.9, P < 0.001; LDFS 2.5, P < 0.0001).

CONCLUSIONS:

In patients with CRC PM, different KRAS mutation subgroups can be determined according to specific codon substitution, with some mutations (KRASMUT1) that could have a similar prognosis to wild-type patients. These findings should be further investigated in larger series.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du péritoine / Tumeurs colorectales / Protéines proto-oncogènes p21(ras) / Mutation Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: ESMO Open / ESMO open Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du péritoine / Tumeurs colorectales / Protéines proto-oncogènes p21(ras) / Mutation Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: ESMO Open / ESMO open Année: 2024 Type de document: Article Pays de publication: Royaume-Uni